N-(4-bromobenzyl)-2-methoxy-N-methylethanamine | 728948-32-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-(4-bromobenzyl)-2-methoxy-N-methylethanamine
• 英文别名: N-(4-bromobenzyl)-N-(2-methoxyethyl)-N-methylamine；N-[(4-bromophenyl)methyl]-2-methoxy-N-methylethanamine
• CAS: 728948-32-1
• 化学式: C₁₁H₁₆BrNO
• mdl: MFCD12027208
• 分子量: 258.158
• InChiKey: GRZPMTOWGXQEPE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  14
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.454
• 拓扑面积：
  12.5
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT

反应信息

• 作为反应物：
  描述：

  N-(4-bromobenzyl)-2-methoxy-N-methylethanamine 、 2-[(氨基羰基)氨基]-5-溴-3-噻吩羧酰胺 、 以The product was obtained directly from the work-up as a brown solid (0.142 g)的产率得到
  参考文献：
  名称：

  THIOPHENE-CARBOXAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF THE ENZYME IKK-2

  摘要：

  本发明涉及式(I)的噻吩羧酰胺，其中A、R1、R2、R3、R4、R5和X如规范中所定义，以及用于其制备的过程和中间体，含有它们的药物组合物以及它们在治疗中的使用。

  公开号：

  US20100029754A1
• 作为产物：
  描述：

  对溴溴苄 、 N-(2-甲氧基乙基)甲基胺 在 乙醚 、 水 、 乙酸乙酯 、 2-甲基戊烷 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 16.0h， 以to give the product as a yellow oil (0.67 g)的产率得到N-(4-bromobenzyl)-2-methoxy-N-methylethanamine
  参考文献：
  名称：

  THIOPHENE-CARBOXAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF THE ENZYME IKK-2

  摘要：

  本发明涉及式(I)的噻吩羧酰胺，其中A、R1、R2、R3、R4、R5和X如规范中所定义，以及用于其制备的过程和中间体，含有它们的药物组合物以及它们在治疗中的使用。

  公开号：

  US20100029754A1

文献信息

• [EN] THIOPHENE-CARBOXAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF THE ENZIME IKK-2<br/>[FR] DERIVES DE THIOPHENE-CARBOXAMIDE ET LEUR UTILISATION COMME INHIBITEURS DE L'ENZYME IKK-2
  申请人：ASTRAZENECA AB

  公开号：WO2004063186A1

  公开（公告）日：2004-07-29

  The invention relates to thiophene carboxamides of formula (I), wherein A, R1, R2, R3, R4, R5 and X are as defined in the specification, processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy .

  该发明涉及式(I)的噻吩羧酰胺，其中A、R1、R2、R3、R4、R5和X如规范中所定义，以及在其制备过程中使用的中间体，含有它们的药物组合物以及它们在治疗中的应用。
• Thiophene-carboxamide derivatives and their use as inhibitors of the enzyme ikk-2
  申请人：Faull Wellington Alan

  公开号：US20060058522A1

  公开（公告）日：2006-03-16

  The invention relates to thiophene carboxamides of formula (I), wherein A, R 1 , R 2 , R 3 , R 4 , R 5 and X are as defined in the specification, processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy.

  本发明涉及式(I)的噻吩羧酰胺，其中A、R1、R2、R3、R4、R5和X如说明书中所定义，以及用于其制备的过程和中间体、含有它们的制药组合物以及它们在治疗中的使用。
• LINCOMYCIN DERIVATIVES AND ANTIMICROBIAL AGENTS COMPRISING THE SAME AS ACTIVE INGREDIENT
  申请人：Wakiyama Yoshinari

  公开号：US20100210570A1

  公开（公告）日：2010-08-19

  An objective of the present invention is to provide compounds of formula (1) or their pharmacologically acceptable salts or solvates wherein A represents aryl; R 1 represents N-optionally substituted C 1-6 alkyl-N-optionally substituted C 1-6 alkylamino-C 1-6 alkyl; R 2 represents a hydrogen atom or optionally substituted C 1-6 alkyl; R 3 represents optionally substituted C 1-6 alkyl or C 3-6 cycloalkyl-C 1-4 alkyl; m is 1 to 3; n is 0; and p is 0 to 2. The compounds are novel lincomycin derivatives that have a potent activity against resistant Streptococcus pneumoniae, which have recently posed problems, in the treatment of infectious diseases. Further, the compounds are usable as antimicrobial agents and are useful for preventing or treating bacterial infectious diseases.

  本发明的目标是提供以下化合物(1)或其药理学上可接受的盐或溶剂，其中A代表芳基；R1代表N-可选取代的C1-6烷基-N-可选取代的C1-6烷基氨基-C1-6烷基；R2代表氢原子或可选取代的C1-6烷基；R3代表可选取代的C1-6烷基或C3-6环烷基-C1-4烷基；m为1至3；n为0；p为0至2。这些化合物是新颖的林可霉素衍生物，对最近在感染性疾病治疗中引起问题的耐药性肺炎链球菌具有强效活性。此外，这些化合物可用作抗微生物药物，有助于预防或治疗细菌感染性疾病。
• LINCOMYCIN DERIVATIVES AND ANTIBACTERIAL AGENTS CONTAINING THE SAME AS THE ACTIVE INGREDIENT
  申请人：Meiji Seika Kaisha Ltd.

  公开号：EP2151447A1

  公开（公告）日：2010-02-10

  An objective of the present invention is to provide compounds of formula (1) or their pharmacologically acceptable salts or solvates wherein A represents aryl; R1 represents N-optionally substituted C1-6 alkyl-N-optionally substituted C1-6 alkylamino-C1-6 alkyl; R2 represents a hydrogen atom or optionally substituted C1-6 alkyl; R3 represents optionally substituted C1-6alkyl or C3-6 cycloalkyl-C1-4 alkyl; m is 1 to 3; n is 0; and p is 0 to 2. The compounds are novel lincomycin derivatives that have a potent activity against resistant Streptococcus pneumoniae, which have recently posed problems, in the treatment of infectious diseases. Further, the compounds are usable as antimicrobial agents and are useful for preventing or treating bacterial infectious diseases.

  本发明的目的是提供式（1）化合物或其药理学上可接受的盐或溶液，其中 A 代表芳基；R1 代表 N-任选取代的 C1-6 烷基-N-任选取代的 C1-6 烷基氨基-C1-6 烷基；R2 代表氢原子或任选取代的 C1-6 烷基；R3 代表任选取代的 C1-6 烷基或 C3-6 环烷基-C1-4 烷基；m 为 1 至 3；n 为 0；p 为 0 至 2。这些化合物是新型的林可霉素衍生物，在治疗传染性疾病方面对耐药性肺炎链球菌有很强的活性，而耐药性肺炎链球菌近来已造成了一些问题。此外，这些化合物还可用作抗菌剂，用于预防或治疗细菌性传染病。
• THIOPHENE-CARBOXAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF THE ENZIME IKK-2
  申请人：AstraZeneca AB

  公开号：EP1583755A1

  公开（公告）日：2005-10-12